Estimated reading time: 3 minutes
Researchers have identified a pain-regulating mechanism in the brain that could eventually lead to more targeted treatments for chronic neuropathic pain. This difficult-to-treat condition can leave patients experiencing persistent shooting, stabbing, or burning pain.
In a mouse study, researchers at Washington University School of Medicine in St. Louis found that mu opioid receptors in the locus coeruleus, a small region at the base of the brain involved in alertness, stress and pain regulation, can act as a brake on chronic pain following nerve injury.
When researchers removed those receptors specifically from locus coeruleus brain cells, mice with neuropathic pain became more sensitive to touch and heat.
The findings, published in Current Biology, could help researchers explore treatments that target this specific brain region rather than opioid receptors throughout the nervous system.
“Millions of adults live with chronic neuropathic pain caused by nerve damage,” said Jordan McCall, PhD, an associate professor in the Center for Clinical Pharmacology in the WashU Medicine Department of Anesthesiology and the study’s senior author. “The pain is difficult to treat, and traditional opioid medications bind to receptors throughout the entire body and brain, often leading to side effects, tolerance, and addiction risk. Understanding how localized receptors in the locus coeruleus act as gatekeepers could lead to more targeted, effective pain therapies with fewer risks.”
Nerve Injury Appears to Change the Brain’s Pain Response
Neuropathic pain develops when damaged nerve fibers send abnormal signals to the brain. The condition can be associated with diabetes, viral infections, and nerve compression, among other causes.
McCall’s team focused on the locus coeruleus because of its established role in pain regulation.
Researchers first confirmed that nerve injury can turn the region into an active driver of pain. When they temporarily shut off locus coeruleus brain cells in mice, animals modeling neuropathic pain showed reduced sensitivity to touch and heat compared with healthy mice.
The team then examined mu opioid receptors in the locus coeruleus. These receptors are found throughout the brain and spinal cord and respond to opioids produced naturally by the body as well as drugs such as morphine and fentanyl. Because the locus coeruleus contains many of these receptors, researchers investigated their role in controlling pain.
Restoring Opioid Receptors Reversed Hypersensitivity in Mice
The researchers deleted mu opioid receptors only from locus coeruleus brain cells in mice with neuropathic pain. Without them, the animals became even more sensitive to touch and heat than mice with intact receptors.
Restoring the receptors to the same neurons reversed the hypersensitivity.
The results suggest that chronic pain may impair the ability of mu opioid receptors to suppress activity in the locus coeruleus. Researchers are now exploring how to manipulate this brain region without affecting receptors elsewhere in the nervous system.
Why This Research Matters for Nurses and Pain Management
The research remains preclinical and was conducted in mice, so the findings do not establish that targeting the locus coeruleus will relieve neuropathic pain in humans.
Still, the study could be significant for nurses and other clinicians who care for patients with chronic nerve pain, particularly because the condition can be difficult to treat and traditional opioids carry risks, including side effects, tolerance, and addiction.
The research also provides insight into why neuropathic pain can persist. The findings suggest that nerve injury may not only generate abnormal pain signals but also interfere with a brain mechanism that normally helps suppress them.
If researchers eventually find a way to target mu opioid receptors specifically within the locus coeruleus, it could provide a more localized approach to pain relief. Further research will be needed to determine whether the mechanism identified in mice can be safely and effectively targeted in humans.
